Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Evaluate Tolerability and Safety of HY209 in Healthy Volunteers
Details : HY-209 is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Dementia.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 01, 2024